Journal Article

Diagnosis and management of precocious sexual maturation: an updated review

de Paula Leila Cristina Pedroso, Lucena Iara Regina Siqueira, Cheuiche, Amanda Veiga, da Silveira Leticia Guimarães, Silveiro Sandra Pinho

2021

Overview

The classic definition of precocious sexual maturation is the development of secondary sexual characteristics before 8 years of age in girls and before 9 years of age in boys. It is classified as central precocious puberty when premature maturation of the hypothalamic-pituitary-gonadal axis occurs, and as peripheral precocious puberty when there is excessive secretion of sex hormones, independent of gonadotropin secretion. Precocious sexual maturation is more common in girls, generally central precocious puberty of idiopathic origin. In boys, it tends to be linked to central nervous system abnormalities. Clinical evaluation should include a detailed history and physical examination, including anthropometric measurements, calculation of growth velocity, and evaluation of secondary sexual characteristics. The main sign to suspect the onset of puberty is breast tissue development (thelarche) in girls and testicular enlargement (≥4 mL) in boys. Hormonal assessment and imaging are required for diagnosis and identification of the etiology. Genetic testing should be considered if there is a family history of precocious puberty or other clinical features suggestive of a genetic syndrome. Long-acting gonadotropin-releasing hormone analogs are the standard of care for central precocious puberty management, while peripheral precocious puberty management depends on the etiology.Conclusion: The aim of this review is to address the epidemiology, etiology, clinical assessment, and management of precocious sexual maturation. What is Known:• The main sign to suspect the onset of puberty is breast tissue development (thelarche) in girls and testicular enlargement (≥4 mL) in boys. The classic definition of precocious sexual maturation is the development of secondary sexual characteristics before 8 years of age in girls and before 9 years of age in boys.• Long-acting gonadotropin-releasing hormone agonist (GnRHa) is the standard of care for CPP management, and adequate hormone suppression results in the stabilization of pubertal progression, a decline in growth velocity, and a decrease in bone age advancement.What is New:• Most cases of precocious sexual maturation are gonadotropin-dependent and currently assumed to be idiopathic, but mutations in genes involved in pubertal development have been identified, such as MKRN3 and DLK1.• A different preparation of long-acting GnRHa is now available: 6-month subcutaneous injection.

• Publisher: Springer Nature B.V
• Subject: Age / Agonists / Breast / Central nervous system / Children & youth / Diagnosis / Enlargement / Epidemiology / Etiology / Genetic screening / Gonadotropin-releasing hormone / Gonadotropins / Hypothalamic-pituitary-gonadal axis / Hypothalamus / Management / Maturation / Medical diagnosis / Physical growth / Pituitary / Pituitary (anterior) / Pituitary-gonadal axis / Preadipocyte factor 1 / Puberty / Secondary sexual characters / Secretion / Sex hormones / Testes / Velocity